Targeting the N-acetyltransferase 10/DKK2 axis enhances CD8+ T cell antitumor activity in colorectal cancer models
Journal of Clinical Investigation · 16.01.2026 · 136 (2)
DOI: 10.1172/jci196722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.01.2026. Verfasst von Mengmeng Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, MOE Innovation Center for Basic Research in Tumor Imm…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, CD8-Positive T-Lymphocytes, Acetyltransferases, Neoplasm Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite overexpression of N-acetyltransferase 10 (NAT10) in colorectal cancer (CRC), its immunomodulatory role in the tumor microenvironment remains elusive. Here, we reveal that NAT10 promotes immune evasion through N4-acetylcytosine–dependent (ac4C-dependent) mRNA stabilization. Using syngeneic mouse models (MC38/CT-26), intestinal epithelial-cell specific Nat10 conditional KO ( Nat10 cKO ) mice, patient-derived organoids, and clinical specimens, we show that Nat10 ablation enhanced CD8 + T cell–mediated antitumor immunity. Single-cell RNA-seq revealed increased cytotoxic CD8 + T cell infiltration in Nat10 cKO tumors, which was corroborated by the inverse correlation of tumoral NAT10 expression and CD8 + T cell number in clinical specimens. Multi-omics integration analysis identified DKK2 as the predominant NAT10-regulated transcript. NAT10 stabilized DKK2 mRNA via ac4C modification, leading to high expression of the DKK2 protein. Secreted DKK2 engaged LRP6 receptors to activate AKT-mTOR signaling, inducing cholesterol accumulation in CD8 + T cells and impairing their cytotoxicity. Pharmacological NAT10 inhibition (Remodelin treatment) or DKK2 neutralization restored CD8 + T cell function and synergized with anti–PD-1 therapy. Our findings establish the NAT10/DKK2/LRP6/AKT-mTOR/cholesterol axis as a critical regulator of CD8 + T cell dysfunction in CRC, positioning NAT10/DKK2 as a potential target to enhance immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University, MOE Innovation Center for Basic Research in Tumor Immunotherapy, Anhui Province Key Laboratory of Tumor Immune Microenviron…
- Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
- Department of Thoracic Surgery, Northern Jiangsu People's Hospital, Yangzhou, China.
- Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
- Department of Geriatric Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
- Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Li, M., Zhao, X., Wu, J., Zhou, S., Fu, Y., Chen, C., Ma, Z., Xu, J., Qian, Y., Wang, Z., Wang, B., Wang, Q., Ding, Q., Chen, C., Wang, H., Yang, X., Dai, W., Zhang, W., & Wang, S. (2026). Targeting the N-acetyltransferase 10/DKK2 axis enhances CD8+ T cell antitumor activity in colorectal cancer models. Journal of Clinical Investigation, 136(2). https://doi.org/10.1172/jci196722
Vancouver
Li M, Zhao X, Wu J, Zhou S, Fu Y, Chen C, et al. Targeting the N-acetyltransferase 10/DKK2 axis enhances CD8+ T cell antitumor activity in colorectal cancer models. Journal of Clinical Investigation. 2026;136(2). doi:10.1172/jci196722
BibTeX
@article{Li2026,
author = {Li, Mengmeng and Zhao, Xiaoya and Wu, Jun and Zhou, Shimeng and Fu, Yao and Chen, Chen and Ma, Zhuang and Xu, Jiawen and Qian, Yun and Wang, Zhangding and Wang, Bo and Wang, Qiang and Ding, Qingqing and Chen, Changyu and Wang, Honggang and Yang, Xiaozhong and Dai, Weijie and Zhang, Wenjie and Wang, Shouyu},
title = {Targeting the N-acetyltransferase 10/DKK2 axis enhances CD8+ T cell antitumor activity in colorectal cancer models},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {2},
doi = {10.1172/jci196722}
}
EUVIMED